MedPath

Fuligo

BM HOMEOPATHIC REMEDY LIQUIDS FULIGO/ BM60

Approved
Approval ID

3b27225f-4587-d915-e063-6294a90a7225

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jul 30, 2025

Manufacturers
FDA

BM Private Limited

DUNS: 645599762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cimicifuga, Drosera, Formica Rufa, Fuligo, Inula hel., Kali mur, lapis albus, silicea

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code85816-2060
Product Classification
G
Generic Name
Cimicifuga, Drosera, Formica Rufa, Fuligo, Inula hel., Kali mur, lapis albus, silicea
Product Specifications
Route of AdministrationORAL
Effective DateJuly 30, 2025
FDA Product Classification

INGREDIENTS (8)

INULA HELENIUM ROOTActive
Quantity: 6 [hp_X] in 1 mL
Code: E55SMD6DA8
Classification: ACTIB
SILICON DIOXIDEActive
Quantity: 6 [hp_X] in 1 mL
Code: ETJ7Z6XBU4
Classification: ACTIB
DROSERA ROTUNDIFOLIA WHOLEActive
Quantity: 6 [hp_X] in 1 mL
Code: QR44N9XPJQ
Classification: ACTIB
POTASSIUM CHLORIDEActive
Quantity: 6 [hp_X] in 1 mL
Code: 660YQ98I10
Classification: ACTIB
ALCOHOLInactive
Quantity: 0.96 mL in 1 mL
Code: 3K9958V90M
Classification: IACT
CALCIUM HEXAFLUOROSILICATEActive
Quantity: 6 [hp_X] in 1 mL
Code: 2NVP93XVQ3
Classification: ACTIB
BLACK COHOSHActive
Quantity: 6 [hp_X] in 1 mL
Code: K73E24S6X9
Classification: ACTIB
FORMICA RUFAActive
Quantity: 6 [hp_X] in 1 mL
Code: 55H0W83JO5
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 1/1/2015

Fuligo

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 1/1/2015

For detail, please read the enclosed package (product information leaflet)

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/1/2015

10-15 drops, 3-4 times a day in some water

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 1/1/2015

alcohol

WARNINGS SECTION

LOINC: 34071-1Updated: 1/1/2015

Precautions/storage:
Keep away from children and store at cool and dry place.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 1/1/2015

Precautions/storage:
Keep away from children and store at cool and dry place.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 1/1/2025

Cimicifuga, Drosera, Formica Rufa, Fuligo, Inula hel, kali mur, lapis albus, silicea

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 1/1/2015

For detail, please read the enclosed package (product information leaflet)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fuligo - FDA Drug Approval Details